ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.93 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,158 | -71.4% | 5,642 | -70.5% | 0.00% | – |
| Q4 2022 | $112,499 | +251.6% | 19,100 | +91.0% | 0.00% | – |
| Q3 2022 | $32,000 | -23.8% | 10,000 | +28.2% | 0.00% | – |
| Q1 2022 | $42,000 | -99.4% | 7,800 | -97.7% | 0.00% | -100.0% |
| Q3 2021 | $6,979,000 | -58.2% | 333,782 | -64.6% | 0.03% | -58.7% |
| Q2 2021 | $16,699,000 | -47.0% | 944,001 | -26.6% | 0.08% | -49.0% |
| Q1 2021 | $31,498,000 | – | 1,285,647 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |